Amit X. Garg, William F. Clark, R. Brian Haynes, Andrew A. House 

Slides:



Advertisements
Similar presentations
Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.
Advertisements

Volume 54, Issue 2, Pages (August 1998)
Effect of beta-blockers on perioperative outcomes in vascular and endovascular surgery: a systematic review and meta-analysis  S Hajibandeh, S Hajibandeh,
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Introduction The American Journal of Medicine
End-stage renal disease in developing countries
Volume 83, Issue 3, Pages (March 2013)
Volume 70, Issue 6, Pages (September 2006)
Progression of renal failure and hypertensive nephrosclerosis
John P. Middleton, Patrick H. Pun  Kidney International 
Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2  Robert N. Foley, Charles A. Herzog, Allan.
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Homocysteine and risk in end-stage renal disease: a matter of context
End-stage renal disease in living kidney donors
Steven G. Coca, Swathi Singanamala, Chirag R. Parikh 
Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease  Johannes F.E. Mann, Qi-Long.
Comorbidity and confounding in end-stage renal disease
Volume 66, Issue 3, Pages (September 2004)
Volume 68, Issue 5, Pages (November 2005)
Volume 70, Issue 11, Pages (December 2006)
Volume 61, Issue 6, Pages (June 2002)
Study of Heart and Renal Protection (SHARP)
U-shaped effect of eGFR and mortality
Acute myocardial infarction in patients with end-stage renal disease
Volume 71, Issue 6, Pages (March 2007)
Volume 70, Issue 12, Pages (December 2006)
Fructose intake as a risk factor for kidney stone disease
Volume 73, Issue 12, Pages (June 2008)
Volume 65, Issue 4, Pages (April 2004)
Does reducing salt intake increase cardiovascular mortality?
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Elevated risk of stroke among patients with end-stage renal disease
Cardiovascular disease in pediatric chronic dialysis patients
Volume 87, Issue 1, Pages (January 2015)
The kidney, a cardiovascular risk marker, and a new target for therapy
Volume 73, Issue 7, Pages (April 2008)
Volume 80, Issue 6, Pages (September 2011)
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Cardiovascular risk factors in chronic kidney disease
Cardiovascular calcification in patients with chronic renal failure: Are we on target with this risk factor?  Peter A. Mccullough, Sandeep Soman  Kidney.
Volume 85, Issue 5, Pages (May 2014)
Prehypertension: is it relevant for nephrologists?
Homocysteine, renal function, and risk of cardiovascular disease
Volume 70, Issue 3, Pages (August 2006)
Cardiovascular risk assessment in kidney transplantation
Volume 80, Issue 12, Pages (December 2011)
Volume 54, Issue 2, Pages (August 1998)
Does equal care give equal outcomes?
Volume 72, Issue 2, Pages (July 2007)
Volume 75, Pages S47-S49 (February 2009)
The Danish Renal Biopsy Register
Volume 70, Issue 7, Pages (October 2006)
Michael R. Lattanzio, Matthew R. Weir  Kidney International 
Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction  Malcolm F. Hand, William G. Haynes, David J.
Is it the low-protein diet or simply the salt restriction?
Volume 64, Issue 4, Pages (October 2003)
Charles A. Herzog  Kidney International 
Is complement a target for therapy in renal disease?
Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley 
Volume 75, Pages S50-S51 (February 2009)
Renal prognosis of toxigenic Escherichia coli infection
Volume 75, Issue 7, Pages (April 2009)
Volume 64, Issue 4, Pages (October 2003)
The conundrum of increased burden of end-stage renal disease in Asians
Familial phenotype differences in PKD11
Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease?  Danilo Fliser, Jan T. Kielstein, Hermann Haller, Stefanie M. Bode-Böger  Kidney.
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Sugar-sweetened beverages and chronic disease
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Presentation transcript:

Moderate renal insufficiency and the risk of cardiovascular mortality: Results from the NHANES I  Amit X. Garg, William F. Clark, R. Brian Haynes, Andrew A. House  Kidney International  Volume 61, Issue 4, Pages 1486-1494 (April 2002) DOI: 10.1046/j.1523-1755.2002.00270.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Independent risk of renal insufficiency on total mortality, adjusted for traditional cardiovascular risk factors. Longitudinal studies are from 1973 to 1999. *Age adjusted rate; **unpublished data provided by the study author. Kidney International 2002 61, 1486-1494DOI: (10.1046/j.1523-1755.2002.00270.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Independent risk of renal insufficiency on cardiovascular events, adjusted for traditional cardiovascular risk factors. Longitudinal studies are from 1973 to 1999. Comparing cardiovascular event rates was problematic because different cardiovascular outcomes are reported in the studies. Here, cardiovascular events preferentially represented cardiovascular mortality or heart failure mortality when reported, or otherwise represented myocardial infarction, stroke, or some composite of cardiovascular disease. *Age adjusted rate. Kidney International 2002 61, 1486-1494DOI: (10.1046/j.1523-1755.2002.00270.x) Copyright © 2002 International Society of Nephrology Terms and Conditions